Literature DB >> 2505081

Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.

T Kouzarides1, E Ziff.   

Abstract

The products of the fos and jun protooncogenes form a stable heterodimer which binds to the TPA-responsive element (TRE) TGACTCA with high affinity. These two proteins, together with the yeast GCN4 protein, belong to a growing family of transcription factors, including FosB, Fra1, JunB and JunD, whose members share a highly conserved DNA-binding domain. This domain is composed of two structures: a basic motif, which is thought to bind directly to DNA; and a leucine zipper, which provides a dimerization interface. Although this domain is highly conserved in Fos, Jun and GCN4, each of these three proteins has very different relative affinities for the TRE. To understand these differences, we used 'domain-swapping' experiments designed to test the relative contributions of the basic motif and the leucine zipper to TRE-binding affinity. Here we show that fos, jun and GCN4 have different affinities for the TRE due to differences in the hetero- or homo-dimerization capacity of their leucine zipper domains; the basic motifs of these three proteins have comparable DNA binding potential. These results indicate that leucine zippers control the types of protein complexes which can associate with a TRE and regulate gene expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505081     DOI: 10.1038/340568a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  82 in total

Review 1.  Immediate early gene expression within the visual system: light and circadian regulation in the retina and the suprachiasmatic nucleus.

Authors:  B L Caputto; M E Guido
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

Review 2.  Nicotinic receptor-associated 43K protein and progressive stabilization of the postsynaptic membrane.

Authors:  J A Hill
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

3.  The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID.

Authors:  C Hagemeier; S Walker; R Caswell; T Kouzarides; J Sinclair
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Construction and expression of a monomeric c-Jun protein that binds and activates transcription of AP-1-responsive genes.

Authors:  T Deng; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

5.  The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters.

Authors:  C Herrero Sanchez; W Reith; P Silacci; B Mach
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

6.  Genetic and sequence organization of the mcrBC locus of Escherichia coli K-12.

Authors:  D Dila; E Sutherland; L Moran; B Slatko; E A Raleigh
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

7.  Mutations that define the optimal half-site for binding yeast GCN4 activator protein and identify an ATF/CREB-like repressor that recognizes similar DNA sites.

Authors:  J W Sellers; A C Vincent; K Struhl
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

8.  Ionizing radiation regulates expression of the c-jun protooncogene.

Authors:  M L Sherman; R Datta; D E Hallahan; R R Weichselbaum; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  A maize DNA-binding factor with a bZIP motif is induced by low temperature.

Authors:  T Kusano; T Berberich; M Harada; N Suzuki; K Sugawara
Journal:  Mol Gen Genet       Date:  1995-09-20

10.  The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.

Authors:  L J Ransone; L D Kerr; M J Schmitt; P Wamsley; I M Verma
Journal:  Gene Expr       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.